Journal of Immunology Research

Next Generation Vaccines for Infectious Diseases


Publishing date
01 Apr 2019
Status
Published
Submission deadline
07 Dec 2018

1University of Georgia, Athens, USA

2Università Vita-Salute San Raffaele, Milan, Italy

3Università Vita-Salute San Raffaele, Milan, Italy


Next Generation Vaccines for Infectious Diseases

Description

Vaccination is one, if not the most, effective approach for controlling the spread of infectious diseases. Depending on the pathogen, a number of strategies have been utilized for developing a vaccine capable of eliciting protective immunity. A historically common vaccine strategy was to inactivate, chemically or thermally, the pathogen in order to elicit an immune response against its components while avoiding the adverse effects of infection. Over the last several decades, a number of more sophisticated vaccine strategies have been developed. As an example, the advent of recombinant protein technology has enabled the development of subunit vaccines that focus the immune response towards specific components of the pathogen. In this regard, the HBsAg-based hepatitis B virus (HBV), the human papillomavirus (HPV), and the serogroup B meningococcal vaccines represent prototypes of this new generation of protein-based immunogens that are now used in clinical practice.

The purpose of this special issue is to publish high-quality research papers and review articles that highlight new as well as under-development vaccine approaches for infectious diseases. Original, high-quality contributions that are not yet published or that are not under review by other journals or peer-reviewed conferences will be evaluated.

Potential topics include but are not limited to the following:

  • Recombinant vaccines
  • Viral vector-based vaccines
  • DNA vaccines
  • Reverse vaccinology
  • Improved vaccine delivery methods
  • Veterinary vaccines
  • Immunological markers and correlates of vaccine-induced protection
  • Evaluation of immunogenicity and efficacy of candidate vaccine adjuvants

Articles

  • Special Issue
  • - Volume 2019
  • - Article ID 9124326
  • - Research Article

New Insights on the Adjuvant Properties of the Leishmania infantum Eukaryotic Initiation Factor

Olga S. Koutsoni | Mourad Barhoumi | ... | Eleni Dotsika
  • Special Issue
  • - Volume 2019
  • - Article ID 5890962
  • - Editorial

Next Generation Vaccines for Infectious Diseases

Giuseppe A. Sautto | Greg A. Kirchenbaum | ... | Francesca Ferrara
  • Special Issue
  • - Volume 2019
  • - Article ID 8732191
  • - Review Article

OMIC Technologies and Vaccine Development: From the Identification of Vulnerable Individuals to the Formulation of Invulnerable Vaccines

Nicola Cotugno | Alessandra Ruggiero | ... | Paolo Palma
  • Special Issue
  • - Volume 2019
  • - Article ID 9804584
  • - Research Article

Reverse Immunology Approach to Define a New HIV-gp41-Neutralizing Epitope

Karim Dorgham | Nicolas Pietrancosta | ... | Vincent Vieillard
  • Special Issue
  • - Volume 2019
  • - Article ID 8303648
  • - Review Article

Alternative Methods of Vaccine Delivery: An Overview of Edible and Intradermal Vaccines

E. Criscuolo | V. Caputo | ... | N. Clementi
  • Special Issue
  • - Volume 2019
  • - Article ID 2463731
  • - Research Article

High-Titre Neutralizing Antibodies to H1N1 Influenza Virus after Mouse Immunization with Yeast Expressed H1 Antigen: A Promising Influenza Vaccine Candidate

Edyta Kopera | Konrad Zdanowski | ... | Bogusław Szewczyk
  • Special Issue
  • - Volume 2018
  • - Article ID 3734207
  • - Review Article

Defensive Driving: Directing HIV-1 Vaccine-Induced Humoral Immunity to the Mucosa with Chemokine Adjuvants

Ebony N. Gary | Michele A. Kutzler
  • Special Issue
  • - Volume 2018
  • - Article ID 8087916
  • - Research Article

An O-Antigen Glycoconjugate Vaccine Produced Using Protein Glycan Coupling Technology Is Protective in an Inhalational Rat Model of Tularemia

Laura E. Marshall | Michelle Nelson | ... | Joann L. Prior
  • Special Issue
  • - Volume 2018
  • - Article ID 8979838
  • - Research Article

Food-Grade Saponin Extract as an Emulsifier and Immunostimulant in Emulsion-Based Subunit Vaccine for Pigs

Yulia Burakova | Rachel Madera | ... | Jishu Shi
  • Special Issue
  • - Volume 2018
  • - Article ID 3143189
  • - Research Article

Efficacy of a Recombinant Turkey Herpesvirus AI (H5) Vaccine in Preventing Transmission of Heterologous Highly Pathogenic H5N8 Clade 2.3.4.4b Challenge Virus in Commercial Broilers and Layer Pullets

Vilmos Palya | Tímea Tatár-Kis | ... | Ádám Dán
Journal of Immunology Research
 Journal metrics
Acceptance rate40%
Submission to final decision91 days
Acceptance to publication32 days
CiteScore3.330
Impact Factor3.404
 Submit

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19.